CUSIP: G8028L107
Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
2,473,835
-
Share change
-
-2,317,562
-
Total reported value
-
$26,673,782
-
Price per share
-
$10.83
-
Number of holders
-
13
-
Value change
-
-$24,094,909
-
Number of buys
-
11
-
Number of sells
-
3
Quarterly Holders Quick Answers
What is CUSIP G8028L107?
CUSIP G8028L107 identifies LGST - TEVOGEN BIO HLDGS INC COM - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2023
-
Previous quarter:
Q2 2023
Recent filing periods for CUSIP G8028L107:
Institutional Holders of TEVOGEN BIO HLDGS INC COM - Stock (LGST) as of Q3 2023
As of 30 Sep 2023,
TEVOGEN BIO HLDGS INC COM - Stock (LGST) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,473,835 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, GLAZER CAPITAL, LLC, Centiva Capital, LP, First Trust Capital Management L.P., WOLVERINE ASSET MANAGEMENT LLC, BERKLEY W R CORP, CANTOR FITZGERALD, L. P., Castle Creek Arbitrage, LLC, Westchester Capital Management, LLC, and Robinson Capital Management, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.